FcγRIIa (CD32) polymorphism and onchocercal skin disease: Implications for the development of severe reactive onchodermatitis (ROD)

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue 6, 2007, Pages 1074-1078

  Ali, Magdi M M ^a,b   ElGhazali, Gehad ^c   Montgomery, Scott M ^d,e   Farouk, Salah E ^a   Nasr, Amre ^a   Noori, Suzan I A ^f,g   Shamad, Mahdi M ^h   Fadlelseed, Omar E ^h   Berzins, Klavs ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b TROPICAL MEDICINE RESEARCH INSTITUTE   (Sudan)

^c UNIVERSITY OF KHARTOUM   (Sudan)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^f Khartoum Teaching Hospital   (Sudan)

^g RASHID HOSPITAL   (United Arab Emirates)

^h UNIVERSITY OF JUBA   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CD32 ANTIGEN; HISTIDINE; IMMUNOGLOBULIN G; FC RECEPTOR; FC RECEPTOR IIA; LEUKOCYTE ANTIGEN; PRIMER DNA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOST PARASITE INTERACTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; ONCHOCERCIASIS; OUTCOME ASSESSMENT; PATHOGENESIS; REACTIVE ONCHODERMATITIS; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; CASE CONTROL STUDY; CHEMISTRY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; MALE; ONCHOCERCA VOLVULUS; PATHOGENICITY; PATHOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SUDAN;

ONCHOCERCA VOLVULUS;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, CD; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUDAN;

EID: 39049095808     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.77.1074     Document Type: Article

References (29)

1. WHO, 2000. Onchocerciasis (River Blindness). The World Health Organization, Geneva, Fact sheet No: 95.
2. WHO, 1995. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ Tech Rep Ser 852: 1-104.
3. Ali MM, Baraka OZ, AbdelRahman SI, Sulaiman SM, Williams JF, Homeida MM, Mackenzie CD, 2003. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history. J Infect Dis 187: 714-717.
4. Gallin MY, Jacobi AB, Buttner DW, Schonberger O, Marti T, Erttmann KD, 1995. Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda). J Exp Med 182: 41-47.
5. Mackenzie CD, Williams JF, Sisley BM, Steward MW, O'Day J, 1985. Variations in host responses and the pathogenesis of human onchocerciasis. Rev Infect Dis 7: 802-808.
6. Murdoch ME, Payton A, Abiose A, Thomson W, Panicker VK, Dyer PA, Jones BR, Maizels RM, Ollier WE, 1997. HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna-London-Manchester Collaboration for Research on Onchocerciasis. Hum Immunol 55: 46-52.
7. Ottesen EA, 1995. Immune responsiveness and the pathogenesis of human onchocerciasis. J Infect Dis 171: 659-671.
8. Hall LR, Lass JH, Diaconu E, Strine ER, Pearlman E, 1999. An essential role for antibody in neutrophil and eosinophil recruitment to the cornea: B cell-deficient (microMT) mice fail to develop Th2-dependent, helminth-mediated keratitis. J Immunol 163: 4970-4975.
9. Hall LR, Diaconu E, Pearlman E, 2001. A dominant role for Fc gamma receptors in antibody-dependent corneal inflammation. J Immunol 167: 919-925.
10. Ravetch JV, Bolland S, 2001. IgG Fc receptors. Annu Rev Immunol 19: 275-290.
11. Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM, 2002. Fcgamma and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients. Lupus 11: 240-248.
12. Sisley BM, Mackenzie CD, Steward MW, Williams JF, O'Day J, Luty AJ, Braga M, el Sheikh H, 1987. Associations between clinical disease, circulating antibodies and C1q-binding immune complexes in human onchocerciasis. Parasite Immunol 9: 447-463.
13. van Sorge NM, van der Pol WL, van de Winkel JG, 2003. FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61: 189-202.
14. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW, 1999. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med 190: 585-590.
15. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ, 1991. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 147: 1338-1343.
16. Tax WJ, Frenken LA, Glaudemans CA, Tamboer WP, Koene RA, 1995. Polymorphism of Fc receptor (Fc gamma RII) is reflected in cytokine release and adverse effects of mIgG1 anti-CD3/TCR antibody during rejection treatment after renal transplantation. Transplant Proc 27: 867-868.
17. Ghalib HW, MacKenzie CD, Kron MA, Williams JF, el Khalifa M, el Sheikh H, 1987. Severe onchocercal dermatitis in the Ethiopian border region of Sudan. Ann Trop Med Parasitol 81: 405-419.
18. Mackenzie CD, Williams JF, Guderian RH, O'Day J, 1987. Clinical responses in human onchocerciasis: parasitological and immunological implications. Ciba Found Symp 127: 46-72.
19. Murdoch ME, Hay RJ, Mackenzie CD, Williams JF, Ghalib HW, Cousens S, Abiose A, Jones BR, 1993. A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol 129: 260-269.
20. Jiang XM, Arepally G, Poncz M, McKenzie SE, 1996. Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). J Immunol Methods 199: 55-59.
21. Rascu A, Repp R, Westerdaal NA, Kalden JR, van de Winkel JG, 1997. Clinical relevance of Fc gamma receptor polymorphisms. Ann N Y Acad Sci 815: 282-295.
22. Bandi C, Trees AJ, Brattig NW, 2001. Wolbachia in filarial nematodes: evolutionary aspects and implications for the pathogenesis and treatment of filarial diseases. Vet Parasitol 98: 215-238.
23. Brattig NW, 2004. Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. Microbes Infect 6: 113-128.
24. Shi YP, Nahlen BL, Kariuki S, Urdahl KB, McElroy PD, Roberts JM, Lal AA, 2001. Feγ receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. J Infect Dis 184: 107-111.
25. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, Ramsey-Goldman R, Peterson MG, Kimberly RP, 1996. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97: 1348-1354.
26. Bliss SK, Butcher BA, Denkers EY, 2000. Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection. J Immunol 165: 4515-4521.
27. Karassa FB, Trikalinos TA, Ioannidis JP, 2004. The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. Biomed Pharmacother 58: 286-291.
28. Doetze A, Satoguina J, Burchard G, Rau T, Loliger C, Fleischer B, Hoerauf A, 2000. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol 12: 623-630.
29. Dafa'Alla TH, Ghalib HW, Abdelmageed A, Williams JF, 1992. The profile of IgG and IgG subclasses of onchocerciasis patients. Clin Exp Immunol 88: 258-263.